Bo King is an Associate Director in Clinical Development at Deciphera Pharmaceuticals, specializing in Phase I-II oncology trials. With over 15 years of experience in translational oncology, they leverage preclinical insights to advance novel therapeutics. Bo earned a PhD from Shinshu University in Japan.
Outside of their primary role, Bo is the founder of a health sciences company and works as a nutraceutical consultant. They are trilingual and have expressed a strong interest in the power of mindset, believing that how one reacts to lifes events is critically important for health and performance.
Unique fact: Bo won an inspiration award for successfully creating the very first in-vivo model for the rare disease AL Amyloidosis while at Janssen.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.